Clinical Trial
[Treatment of non-specific menometrorrhagia with naftazone]
[Article in
French]
- PMID: 6384352
Item in Clipboard
Clinical Trial
[Treatment of non-specific menometrorrhagia with naftazone]
[Article in
French]
J Gynecol Obstet Biol Reprod (Paris).
1984.
Abstract
The authors carried out a double blind study of the action of naftazone in non-specific menometrorrhagias caused by a uterine device, the oral contraceptive and medroxyprogesterone, in 25 patients. They show a great improvement with the periods becoming normal and metrorrhagia disappearing in 12 out of 13 cases where naftazone was used and in only 1 out of 12 cases where the placebo was used.
Similar articles
-
[Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception].Contracept Fertil Sex (Paris). 1985 May;13(5):721-5. Contracept Fertil Sex (Paris). 1985. PMID: 12267101 French.
-
[Use of epsilon aminocaproic acid in abnormal hemorrhage using intrauterine contraceptive devices].Rev Colomb Obstet Ginecol. 1969 Jul-Aug;20(4):273-8. Rev Colomb Obstet Ginecol. 1969. PMID: 5356119 Spanish.
-
Management of uterine bleeding by PGs or their synthesis inhibitors.Adv Prostaglandin Thromboxane Res. 1980;8:1459-63. Adv Prostaglandin Thromboxane Res. 1980. PMID: 6769315
-
Adrenosem therapy for bleeding coincident with the use of intrauterine contraceptive devices: a double blind study.Fertil Steril. 1970 Mar;21(3):230-3. doi: 10.1016/s0015-0282(16)37388-5. Fertil Steril. 1970. PMID: 4907971 Clinical Trial. No abstract available.
-
The current status of intra-uterine contraceptive devices and systems.Br J Fam Plann. 2000 Jan;26(1):14-5. Br J Fam Plann. 2000. PMID: 10819587 Review. No abstract available.